New insights into markers for distinguishing neuroendocrine prostate cancer: evidence from single-cell analysis
Combined single-cell and bulk analysis, we highlight the cellular heterogeneity and transcriptional programs, validated novel biomarkers of NEPC. Providing a foundation for early prediction of NEPC and management.
Authors
- Wang Hong-qun
- Boyang Li (ORCID: https://orcid.org/0000-0001-5407-4732)
- Zongyao Hao (ORCID: https://orcid.org/0000-0003-3399-3689)
- Qintao Ge (ORCID: https://orcid.org/0000-0001-5040-6699)
- Chang Yin Liang (ORCID: https://orcid.org/0000-0003-2317-1323)
- Meng Zhang (ORCID: https://orcid.org/0000-0003-4935-4005)
- Hailang Luo
Institutions
- Shanghai Medical College of Fudan University (CN)
- Bengbu Medical College (CN)
- Anhui Medical University (CN)
- Fudan University Shanghai Cancer Center (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-03-14
- DOI
- https://doi.org/10.3389/fimmu.2025.1551815
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00